Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SPX Technologies, Inc. Director's Dealing 2021

Mar 3, 2021

30660_dirs_2021-03-03_2277c9a0-e27a-4801-9d7b-5f2a954bc2c7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SPX CORP (SPXC)
CIK: 0000088205
Period of Report: 2021-03-01

Reporting Person: Data J Randall (Pres. - S. Africa & Global Op.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-01 Common Stock A 10365 Acquired 96813 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-01 Employee stock option to purchase common stock $58.34 A 8911 Acquired 2031-03-01 Common Stock (8911) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2928 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee stock option to purchase common stock $27.40 2027-03-01 Common Stock (18471) 18471 Direct
Employee stock option to purchase common stock $32.69 2028-02-22 Common Stock (16326) 16326 Direct
Employee stock option to purchase common stock $36.51 2029-02-21 Common Stock (16138) 16138 Direct
Employee stock option to purchase common stock $50.09 2030-02-20 Common Stock (11959) 11959 Direct

Footnotes

F1: Grant of restricted stock units under the SPX Corporation 2019 Stock Compensation Plan.

F2: Includes unvested restricted stock units.

F3: Vests in three equal installments beginning on March 1, 2018.

F4: Vests in three equal installments beginning on February 22, 2019.

F5: Vests in three equal installments beginning on February 21, 2020.

F6: Vests in three equal installments beginning on February 20, 2021.

F7: Grant of stock option pursuant to the SPX Corporation 2019 Stock Compensation Plan.

F8: Vests in three equal installments beginning on March 1, 2022.